$28.26
-0.230 (-0.81%)
At Close: Jun 03, 2026
STAAR Surgical Board of Directors Unanimously Believes Alcon Merger Maximizes Value for STAAR Stockholders
09:10am, Tuesday, 16'th Sep 2025
LAKE FOREST, Calif.--(BUSINESS WIRE)--STAAR Surgical Company (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, t
MILWAUKEE--(BUSINESS WIRE)--The Ademi Firm continues to investigate STAAR (NASDAQ: STAA) for possible breaches of fiduciary duty and other violations of law in its transaction with Alcon Inc. Click he
STAA Stock Alert: Halper Sadeh LLC is Investigating Whether the Sale of STAAR Surgical Company is Fair to Shareholders
07:00am, Thursday, 11'th Sep 2025
NEW YORK, Sept. 11, 2025 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of STAAR Surgical Company (NASDAQ: STAA) to Alcon for $28.00 per share in
Johnson Fistel Investigates Fairness of Proposed Sale of STAAR Surgical
02:25pm, Tuesday, 09'th Sep 2025
SAN DIEGO, Sept. 09, 2025 (GLOBE NEWSWIRE) -- Shareholder rights law firm Johnson Fistel, PLLP continues its investigation into whether the board members of STAAR Surgical Company (NASDAQ: STAA) breac
STAAR Surgical Reiterates Compelling, Premium Cash Value Provided by Alcon Merger
05:41pm, Tuesday, 02'nd Sep 2025
LAKE FOREST, Calif.--(BUSINESS WIRE)--STAAR Surgical Company (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, i
Alcon Reports Second-Quarter 2025 Results, Launched Tryptyr and Announced Acquisition of STAAR Surgical
04:30pm, Tuesday, 19'th Aug 2025
GENEVA--(BUSINESS WIRE)--Alcon Reports Second-Quarter 2025 Results, Launched Tryptyr and Announced Acquisition of STAAR Surgical.
Staar Surgical (STAA) International Revenue in Focus: Trends and Expectations
10:16am, Monday, 11'th Aug 2025
Examine Staar Surgical's (STAA) international revenue patterns and their implications on Wall Street's forecasts and the prospective trajectory of the stock.
MILWAUKEE--(BUSINESS WIRE)--The Ademi Firm is investigating STAAR (NASDAQ: STAA) for possible breaches of fiduciary duty and other violations of law in its transaction with Alcon Inc. Click here to le
SHAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of STAAR Surgical Company (NASDAQ: STAA)
06:49pm, Thursday, 07'th Aug 2025
NEW YORK , Aug. 7, 2025 /PRNewswire/ -- Class Action Attorney Juan Monteverde with Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered millions of dollars for shareholders an
NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of S
Staar Surgical (STAA) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates
07:32pm, Wednesday, 06'th Aug 2025
Although the revenue and EPS for Staar Surgical (STAA) give a sense of how its business performed in the quarter ended June 2025, it might be worth considering how some key metrics compare with Wall S
STAAR Surgical (STAA) Q2 Revenue Tops 9%
07:13pm, Wednesday, 06'th Aug 2025
STAAR Surgical (STAA) Q2 Revenue Tops 9%
Staar Surgical (STAA) Reports Q2 Loss, Beats Revenue Estimates
06:21pm, Wednesday, 06'th Aug 2025
Staar Surgical (STAA) came out with a quarterly loss of $0.07 per share versus the Zacks Consensus Estimate of a loss of $0.56. This compares to earnings of $0.33 per share a year ago.
STAAR Surgical Reports Second Quarter 2025 Results
04:01pm, Wednesday, 06'th Aug 2025
LAKE FOREST, Calif.--(BUSINESS WIRE)--STAAR Surgical Company (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, t
Johnson Fistel Investigates Fairness of Proposed Sale of STAAR Surgical
02:15pm, Tuesday, 05'th Aug 2025
SAN DIEGO, Aug. 05, 2025 (GLOBE NEWSWIRE) -- Shareholder rights law firm Johnson Fistel, PLLP has launched an investigation into whether the board members of STAAR Surgical Company (NASDAQ: STAA) brea
Sign In
Buy STAA